Patents by Inventor Brian Bernick
Brian Bernick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240358839Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: November 22, 2023Publication date: October 31, 2024Applicant: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick, Neda IRANI
-
Patent number: 11865179Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: GrantFiled: June 15, 2021Date of Patent: January 9, 2024Assignee: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H. R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick, Neda Irani
-
Patent number: 11266661Abstract: Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).Type: GrantFiled: December 7, 2016Date of Patent: March 8, 2022Assignee: TherapeuticsMD, Inc.Inventors: Sebastian Mirkin, Julia M. Amadio, Brian Bernick
-
Publication number: 20220040307Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: June 15, 2021Publication date: February 10, 2022Applicant: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick, Neda IRANI
-
Publication number: 20220016133Abstract: Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).Type: ApplicationFiled: December 7, 2016Publication date: January 20, 2022Inventors: Sebastian Mirkin, Julia M. Amadio, Brian Bernick
-
Patent number: 11033626Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: GrantFiled: September 20, 2019Date of Patent: June 15, 2021Assignee: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H. R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick, Neda Irani
-
Publication number: 20200268888Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: September 20, 2019Publication date: August 27, 2020Applicant: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick
-
Publication number: 20190381068Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: February 12, 2019Publication date: December 19, 2019Applicant: TherapeuticsMD, Inc.Inventors: Julia AMADIO, Brian Bernick, Peter H.R. Persicaner
-
Publication number: 20190358243Abstract: Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).Type: ApplicationFiled: December 7, 2016Publication date: November 28, 2019Inventors: Sebastian Mirkin, Julia M. Amadio, Brian Bernick
-
Patent number: 10471148Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: GrantFiled: March 9, 2017Date of Patent: November 12, 2019Assignee: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H. R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick
-
Publication number: 20180055855Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: August 2, 2017Publication date: March 1, 2018Applicant: TherapeuticsMD, Inc.Inventors: Julia AMADIO, Brian BERNICK, Peter H.R. PERSICANER
-
Publication number: 20170340739Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: March 9, 2017Publication date: November 30, 2017Applicant: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick
-
Publication number: 20170000803Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: September 6, 2016Publication date: January 5, 2017Applicant: TherapeuticsMD, Inc.Inventors: Julia Amadio, Brian Bernick, Peter H.R. Persicaner
-
Publication number: 20150202211Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: March 27, 2015Publication date: July 23, 2015Applicant: TherapeuticsMD, Inc.Inventors: Julia Amadio, Brian Bernick
-
Publication number: 20150196640Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: March 27, 2015Publication date: July 16, 2015Applicant: THERAPEUTICSMD, INC.Inventors: Janice Cacase, Peter Persicaner, Thorsteinn Thorsteinnson, Frederick Sancillio, Julia Amadio, Brian Bernick
-
Patent number: 8577716Abstract: A research and development system that gathers feedback from patients and healthcare providers with respect to the their experience with various aspects of a supplier's products in order to tabulate, consolidate, compare and analyze the data received rapidly and efficiently, and which can be used on successive iterations to determine future products and services.Type: GrantFiled: September 17, 2009Date of Patent: November 5, 2013Assignee: TherapeuticsMD, Inc.Inventors: Brian Bernick, Robert Finizio, John Milligan
-
Publication number: 20120130737Abstract: In various embodiments, a research and development system that gathers feedback from patients and healthcare providers with respect to the their experience with various aspects of a supplier's products in order to tabulate, consolidate, compare and analyze the data received rapidly and efficiently, and which can be used on successive iterations to determine future products and services.Type: ApplicationFiled: January 30, 2012Publication date: May 24, 2012Applicant: THERAPEUTICSMD, INC.Inventors: Robert Finizio, Brian Bernick, John Milligan
-
Publication number: 20110066473Abstract: A research and development system that gathers feedback from patients and healthcare providers with respect to the their experience with various aspects of a supplier's products in order to tabulate, consolidate, compare and analyze the data received rapidly and efficiently, and which can be used on successive iterations to determine future products and services.Type: ApplicationFiled: September 17, 2009Publication date: March 17, 2011Applicant: vitaMedMD, LLCInventors: Brian Bernick, Robert Finizio, John Milligan
